AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

This announcement follows AstraZeneca’s earlier $3.5 billion commitment to the U.S., unveiled in late 2024, and underscores ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

April 9: Trump's higher "reciprocal tariffs" begin just after midnight. Hours later, the president says he is issuing a 90-day pause on those duties, except for China. Trump raises tariffs on Chinese ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

CANBERRA, July 9 (Xinhua) -- The Australian government is very concerned about U.S. threats to impose increased tariffs on pharmaceutical and copper imports, Treasurer Jim Chalmers said on Wednesday.